DUBLIN--(BUSINESS WIRE)--The 'Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region' report has been added to ResearchAndMarkets.com's offering.

都柏林——（商业新闻短讯）——ResearchAndMarkets.com的产品中增加了“连接药物输送设备市场行业趋势和2035年全球预测：按设备类型、连接方式、给药途径、治疗区域和地理区域的分布”报告。（The Connected Drug Delivery Devices Market Industries Trends and Global Predictions to 2035:Distribution by Type of Device，Mode of Connectivity，Route of Admin。

The Connected Drug Delivery Devices Market is valued at USD 4.4 billion in 2024 and is projected to grow at a CAGR of 10.1%, during the forecast period till 2035.

2024年，联网药物输送设备市场的价值为44亿美元，预计到2035年，其复合年增长率将达到10.1%。

Non-compliance with prescribed medications is a prevalent issue in the healthcare industry, contributing to poor health outcomes (including chronic disease progression and high risk of mortality), increased cases of hospitalization and high healthcare costs. Studies reveal that around 66% of the people in the US are prescribed at least one medicine; of these, 50% are not taken by patients as directed by the physicians.

不遵守处方药是医疗保健行业普遍存在的问题，导致健康状况不佳（包括慢性疾病进展和高死亡风险），住院病例增加和医疗保健费用高昂。研究表明，美国约66%的人至少服用一种药物；其中，50%的患者没有按照医生的指示服用。

The factors contributing to the non-adherence towards medications include patient forgetfulness, perception of associated side effects, difficulty in accessing medications, complicated dosing schedules and lack of access to adequate healthcare services..

导致不依从药物的因素包括患者健忘，对相关副作用的感知，难以获得药物，复杂的给药时间表以及缺乏足够的医疗保健服务。。

Notably, poor adherence to medication regimen poses a substantial financial burden on the healthcare system; specifically in the US, it costs around USD 290 billion annually. In order to address this concern, various strategies are being employed, such as simplifying the dosage regimens, offering personalized medication schedules, educating the patients and providing behavioral support..

值得注意的是，对药物治疗方案的依从性差，给医疗保健系统带来了巨大的经济负担；特别是在美国，每年的成本约为2900亿美元。为了解决这个问题，正在采用各种策略，例如简化剂量方案，提供个性化的药物治疗时间表，教育患者并提供行为支持。。

Connected drug delivery devices turn out to be a significant advancement in this area. These are characterized as advanced medical devices that are designed to improve drug administration and monitoring, using digital technologies. These devices are embedded with advanced features and sensors, and have wireless connectivity capabilities, enabling convenient connection to mobile applications, digital health platforms and electronic health records.

连接的药物输送设备证明是这一领域的重大进步。这些设备的特点是先进的医疗设备，旨在利用数字技术改善药物管理和监测。这些设备嵌入了先进的功能和传感器，并具有无线连接功能，可以方便地连接到移动应用程序、数字健康平台和电子健康记录。

These devices enable real-time collection and transfer of data related to patients medication usage, compliance and overall health status, allowing remote monitoring of patient (to enable timely interventions), analyzing disease patterns (to optimize treatment plans), sharing reminders / alerts to patients (to follow their dosage schedules consistently), encouraging participation of patients in their health management and reducing the overall healthcare expenditures..

这些设备能够实时收集和传输与患者用药情况、依从性和整体健康状况相关的数据，允许远程监测患者（以便及时干预），分析疾病模式（优化治疗计划），向患者共享提醒/警报（始终如一地遵循他们的剂量时间表），鼓励患者参与健康管理并减少整体医疗支出。。

It is noteworthy that various add-on sensors are also being developed that are useful in transforming conventional drug delivery devices into advanced ones. With the growing demand for accurate and effective digital health solutions and advancement in technologies (integration with telehealth platforms), the global connected drug delivery devices market is poised to witness steady growth, in the future outlook..

值得注意的是，还正在开发各种附加传感器，这些传感器可用于将常规药物输送装置转变为先进的装置。随着对准确有效的数字健康解决方案的需求不断增长以及技术的进步（与远程保健平台的集成），全球联网药物输送设备市场在未来的前景中有望稳步增长。。

Research Coverage:

研究范围：

The market report on Connected Drug Delivery Devices covers the following elements:

有关联网药物输送设备的市场报告包括以下内容：

An introduction to medication adherence, highlighting the different digital solutions that enhance a patient's ability to follow their prescribed dosage regimens. The chapter also includes details about the connected / smart drug delivery systems, their different types, key features and development processes involved.

介绍药物依从性，重点介绍不同的数字解决方案，以增强患者遵循规定剂量方案的能力。本章还包括有关连接/智能药物输送系统的详细信息，它们的不同类型，关键功能和涉及的开发过程。

Further, it outlines the regulatory guidelines governing the development and approval of connected / smart drug delivery systems..

此外，它概述了管理连接/智能药物输送系统开发和批准的监管指南。。

An insightful analysis of the overall connected drug delivery devices market landscape, featuring information on several relevant parameters, such as stage of development, launch year of device, type of integrated device, route of administration, therapeutic area, target indication, key features, mode of connectivity, availability of companion mobile application and availability of data storage / cloud platform.

对整体互联药物输送设备市场格局进行了深入分析，其中包括几个相关参数的信息，例如开发阶段，设备发布年份，集成设备类型，给药途径，治疗区域，目标适应症，关键功能，连接模式，配套移动应用程序的可用性以及数据存储/云平台的可用性。

In addition, it also encompasses tabulated information on regulatory approvals, geographical reach and drugs compatible with connected / smart drug delivery devices. Further, the chapter includes the list of companies engaged in manufacturing connected drug delivery devices, along with detailed analysis based on various parameters, such as year of establishment, company size, location of headquarters and most active players..

此外，它还包括有关监管批准，地理范围和与连接/智能药物输送设备兼容的药物的列表信息。此外，本章还列出了从事制造联网药物输送设备的公司名单，并根据各种参数进行了详细分析，如成立年份、公司规模、总部位置和最活跃的参与者。。

An extensive analysis of the overall market landscape of add-on sensors, featuring insights based on several relevant parameters, such as stage of development, launch year of device, compatible device, route of administration, therapeutic area, target indication, key features, mode of connectivity, availability of companion mobile application and availability of data storage / cloud platform.

对附加传感器的整体市场前景进行了广泛分析，根据几个相关参数提供了见解，例如开发阶段、设备发布年份、兼容设备、给药途径、治疗领域、目标指示、关键功能、连接模式、配套移动应用程序的可用性以及数据存储/云平台的可用性。

It also includes tabulated information on regulatory approvals, geographical reach and drugs that can be delivered using add-on sensors. Further, the chapter presents a list of companies engaged in manufacturing add-on sensors for drug delivery devices, along with detailed analysis based on various parameters, such as year of establishment, company size, location of headquarters and most active players..

它还包括有关监管批准，地理范围和可以使用附加传感器交付的药物的列表信息。此外，本章列出了从事制造药物输送装置附加传感器的公司名单，并根据各种参数进行了详细分析，例如成立年份，公司规模，总部位置和最活跃的参与者。。

An insightful competitiveness analysis of the connected drug delivery devices and add-on sensors, based on the manufacturer strength. A comprehensive set of profiles of leading players manufacturing connected drug delivery devices, based in North America, Europe and Asia-Pacific, wherein each profile features a brief overview of the company, financial information, connected drug delivery devices portfolio, recent developments and an informed future outlook..

基于制造商的实力，对连接的药物输送设备和附加传感器进行了深入的竞争力分析。北美、欧洲和亚太地区制造联网药物输送设备的领先厂商的全面概况，其中每个概况都简要介绍了公司概况、财务信息、联网药物输送设备组合、最新发展和明智的未来展望。。

An in-depth analysis of completed and ongoing clinical trials related to connected drug delivery devices, during the time period pre-2011-2020, based on several relevant parameters, such as trial registration year, enrolled patient population, trial phase, trial status, type of device, type of sponsor / collaborator, therapeutic area, study design, leading industry players, leading connected / smart drug delivery devices and geography..

根据几个相关参数，如试验注册年份、登记患者人数、试验阶段、试验状态、设备类型、赞助商/合作者类型、治疗领域、研究设计、领先行业参与者、领先的连接/智能药物输送设备和地理位置，对2011-2020年之前完成的和正在进行的与连接药物输送设备相关的临床试验进行深入分析。。

An exhaustive list of the partnerships and collaborations, inked between various stakeholders in the connected drug delivery devices market, which have been analyzed based on several parameters, such as year of partnership, type of partnership, class of device, type of integrated device, compatible device and most active players.

。

It also provides analysis of the regional distribution of the companies involved in these agreements..

它还对参与这些协议的公司的区域分布进行了分析。。

A comprehensive discussion of the funding and investments raised by connected drug delivery device manufacturers, during the period 2020-2024, based on relevant parameters, such as year of funding, amount invested, type of funding, class of device, geography, most active players and most active investors..

根据相关参数，如资金年份、投资金额、资金类型、设备类别、地理位置、最活跃的参与者和最活跃的投资者，全面讨论2020-2024年期间互联药物输送设备制造商筹集的资金和投资。。

An in-depth value chain analysis featuring a discussion on various steps involved in the development of connected / smart drug delivery devices, including R&D, product manufacturing and assembly, product distribution, marketing and sales, and post-market surveillance, along with the information on cost requirements across each of the aforementioned stages..

深入的价值链分析，讨论了开发连接/智能药物输送设备所涉及的各个步骤，包括研发、产品制造和组装、产品分销、营销和销售以及上市后监测，以及上述每个阶段的成本要求信息。。

Detailed case studies on the two most prevalent diseases (namely, asthma and diabetes), featuring a brief description of the disease, its epidemiology, economic burden (imposed due to non-adherence to prescribed treatments), and a summary of the evolution of drug delivery devices and other strategies focused on improving therapy adherence among patients suffering from the indication..

关于两种最常见疾病（即哮喘和糖尿病）的详细案例研究，简要描述了该疾病，其流行病学，经济负担（由于不遵守规定的治疗而产生），并总结了药物输送装置的演变和其他策略，重点是提高患有该适应症的患者的治疗依从性。。

An informative summary of various guidelines established and issued by major regulatory bodies for the approval of connected drug delivery devices, across different countries / geographical regions.

。

A thorough discussion on industry affiliated trends, opportunities and challenges, under a SWOT analysis, which are likely to impact the evolution of connected drug delivery devices market; it includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on industry dynamics..

在SWOT分析下，深入讨论行业相关的趋势，机遇和挑战，这些趋势，机遇和挑战可能会影响联网药物输送设备市场的演变；它包括Harvey ball分析，强调了每个SWOT参数对行业动态的相对影响。。

A comprehensive assessment of the current market size and opportunity, and future growth potential for the connected drug delivery device manufacturers over the next decade.

全面评估当前市场规模和机会，以及未来十年连接药物输送设备制造商的未来增长潜力。

Key Companies Profiled

主要公司简介

Leader players in the connected drug delivery devices market include:

互联药物输送设备市场的主要参与者包括：

Bigfoot Biomedical

BIOCORP

生物公司

Eitan Medical

Eitan Medical公司

E3D Elcam Drug Delivery Device

E3D Elcam药物输送装置

EoFlow

EoFlow

Gerresheimer

格雷斯海姆

Insulet

胰岛素

Medtronic

美敦力

Medtrum

联合会议室

Nemera

停下

Phillips-Medisize

菲利普斯中型

Roche

罗氏公司

Sonceboz

阳光

SOOIL Development

SOOIL开发

Tandem Diabetes Care

串联糖尿病护理

West Pharmaceutical Services

西部制药服务

Ypsomed

Ypsomed

Excel Data Packs

Excel数据包

Connected / Smart Drug Delivery Devices - Market Landscape

联网/智能药物输送设备-市场前景

Add-on Sensors - Market Landscape

附加传感器-市场前景

Product Competitiveness Analysis

产品竞争力分析

Clinical Trial Analysis

临床试验分析

Funding and Investments Analysis

资金和投资分析

Partnerships and Collaborations

伙伴关系和合作

Market Forecast and Opportunity Analysis

市场预测和机会分析

Key Topics Covered:

涵盖的关键主题：

1. PREFACE

2. RESEARCH METHODOLOGY

2、研究方法

3. MARKET DYNAMICS

3、市场动态

4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

经济和其他项目特定考虑因素

5. EXECUTIVE SUMMARY

5、执行摘要

6. INTRODUCTION

6、简介

6.1. Chapter Overview

六点一。章节概述

6.2. Medication Adherence

六点二。药物治疗依从性

6.3. Overview of Connected / Smart Drug Delivery Devices

六点三。连接/智能药物输送设备概述

6.4. Key Design Features and Development Process

六点四。主要设计特点和开发过程

6.5. Classification of Connected / Smart Drug Delivery Devices

六点五。连接/智能药物输送设备的分类

6.6. Regulatory Guidelines for Connected / Smart Drug Delivery Devices

六点六。连接/智能药物输送设备的监管指南

6.7. Advantages and Limitations of Connected / Smart Drug Delivery Devices

六点七。连接/智能药物输送设备的优点和局限性

6.8. Impact of COVID-19 on Connected / Smart Drug Delivery Devices Domain

六点八。新型冠状病毒肺炎对连接/智能给药装置领域的影响

6.9. Future Perspectives

六点九。未来展望

7. MARKET LANDSCAPE: CONNECTED / SMART DRUG DELIVERY DEVICES

7、市场前景：联网/智能药物输送设备

8. MARKET LANDSCAPE: ADD-ON SENSORS

8、市场前景：附加传感器

9. PRODUCT COMPETITIVENESS ANALYSIS

9、产品竞争力分析

10. COMPANY PROFILES: CONNECTED / SMART DRUG DELIVERY DEVICE MANUFACTURERS BASED IN NORTH AMERICA

10、公司简介：北美联网/智能药物输送设备制造商

Leading Connected / Smart Drug Delivery Device Manufacturers

领先的联网/智能药物输送设备制造商

Medtronic

美敦力

Insulet

胰岛素

Tandem Diabetes Care

串联糖尿病护理

Other Prominent Connected / Smart Drug Delivery Device Manufacturers

其他著名的联网/智能药物输送设备制造商

Bigfoot Biomedical

大脚怪生物医学

Phillips-Medisize

菲利普斯中型

West Pharmaceutical Services

西部制药服务

11. COMPANY PROFILES: CONNECTED / SMART DRUG DELIVERY DEVICE MANUFACTURERS BASED IN EUROPE

11、公司简介：欧洲联网/智能药物输送设备制造商

Leading Connected / Smart Drug Delivery Device Manufacturers

领先的联网/智能药物输送设备制造商

BIOCORP

生物公司

Gerresheimer

格雷斯海姆

Roche

罗氏公司

Ypsomed

Ypsomed

Nemera

停下

Sonceboz

阳光

12. COMPANY PROFILES: CONNECTED / SMART DRUG DELIVERY DEVICE MANUFACTURERS BASED IN ASIA-PACIFIC AND REST OF THE WORLD

12、公司简介：亚太地区和世界其他地区的联网/智能药物输送设备制造商

Leading Connected / Smart Drug Delivery Device Manufacturers

领先的联网/智能药物输送设备制造商

Medtrum

联合会议室

SOOIL Development

SOOIL开发

EOFlow

EOFlow

Other Prominent Connected / Smart Drug Delivery Device Manufacturers

其他著名的联网/智能药物输送设备制造商

Eitan Medical

Eitan Medical公司

E3D Elcam Drug Delivery Device

E3D Elcam药物输送装置

13. CLINICAL TRIAL ANALYSIS

13、临床试验分析

14. PARTNERSHIPS AND COLLABORATIONS

14、伙伴关系与合作

15. FUNDING AND INVESTMENTS

15、资金和投资

15.1. Chapter Overview

15.1条。章节概述

15.2. Funding Models

15.2条。融资模式

15.3. Connected / Smart Drug Delivery Devices: Funding and Investments, 2015-2020

15.3条。联网/智能药物输送设备：资金和投资，2015-2020

15.4. Summary of Funding and Investments, Till 2020

15.4条。截至2020年的资金和投资摘要

15.5. Connected / Smart Drug Delivery Devices: Funding and Investments, 2021-2024

15.5条。联网/智能药物输送设备：资金和投资，2021-2024

16. VALUE CHAIN / COST PRICE ANALYSIS

16、价值链/成本价格分析

16.1. Chapter Overview

16.1条。章节概述

16.2. Connected / Smart Drug Delivery Devices: Value Chain

十六点二。连接/智能药物输送设备：价值链

16.3. Cost Distribution Across the Value Chain

16.3条。

17. REGULATORY LANDSCAPE FOR CONNECTED / SMART DRUG DELIVERY DEVICES

17、互联/智能药物输送设备的监管格局

18. CASE STUDIES: APPLICATION OF CONNECTED DRUG DELIVERY DEVICES TO IMPROVE MEDICATION ADHERENCE

案例研究：应用连接的药物输送装置来提高药物依从性

Case Study I: Diabetes

案例研究I：糖尿病

Case Study II: Asthma

19. SWOT ANALYSIS

19、SWOT分析

Strengths

优势

Ability to Minimize / Eliminate Medication Errors

减少/消除用药错误的能力

Economic Advantages

经济优势

Technological Advancements

技术进步

Weaknesses

弱点

Cybersecurity

网络安全

Stringent Regulatory Approvals

严格的监管批准

High Developmental Costs

高开发成本

Opportunities

机会

Growing Prevalence of Chronic Disorders

慢性疾病患病率不断上升

Increasing Adoption of Digital Health Technologies

越来越多地采用数字健康技术

Rising Partnership and Investment Activity

不断增长的伙伴关系和投资活动

Threats

威胁

Material Compatibility Issues

材料兼容性问题

Availability of Alternative Drug Delivery Devices

替代药物输送装置的可用性

Concern Related to Product Recalls in Past

过去与产品召回有关的担忧

20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET

20、全球互联给药设备市场

21. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE OF DEVICE

21、按设备类型划分的连接药物输送设备市场

22. CONNECTED DRUG DELIVERY DEVICES MARKET, BY MODE OF CONNECTIVITY

22、按连接方式划分的互联给药设备市场

23. CONNECTED DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

23、按给药途径划分的互联给药设备市场

24. CONNECTED DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC AREA

24、按治疗领域划分的互联药物输送设备市场

25. CONNECTED DRUG DELIVERY DEVICES MARKET, BY GEOGRAPHICAL REGIONS

25、按地理区域划分的互联药物输送设备市场

26. CONCLUDING REMARKS

26、结束语

27. EXECUTIVE INSIGHTS

27、执行见解

Phillips-Medisize

菲利普斯中型

Cognita Labs

Cognita实验室

Portal Instruments

门户工具

Enable Injections

启用注入

Amiko

阿米科

Elcam Medical

Elcam医疗

West Pharmaceutical Services

西部制药服务

Avoset Health (acquired by Eitan Medical)

Avoset Health（由Eitan Medical收购）

Phillips-Medisize

菲利普斯中型

Sorrel Medical (acquired by LTS lohmann therapie-systeme)

Sorrel Medical（由LTS lohmann therapie systeme收购）

etectRx

etectRx

For more information about this report visit https://www.researchandmarkets.com/r/hzccgl

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/hzccgl

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。